Acorah Software Products - Accounts Production 16.1.300 false true 30 June 2023 1 July 2022 false 1 July 2023 30 June 2024 30 June 2024 12669110 Mr VIMALKUMAR PATEL iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12669110 2023-06-30 12669110 2024-06-30 12669110 2023-07-01 2024-06-30 12669110 frs-core:CurrentFinancialInstruments 2024-06-30 12669110 frs-core:Non-currentFinancialInstruments 2024-06-30 12669110 frs-core:MotorVehicles 2024-06-30 12669110 frs-core:MotorVehicles 2023-07-01 2024-06-30 12669110 frs-core:MotorVehicles 2023-06-30 12669110 frs-core:ShareCapital 2024-06-30 12669110 frs-core:RetainedEarningsAccumulatedLosses 2024-06-30 12669110 frs-bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12669110 frs-bus:FilletedAccounts 2023-07-01 2024-06-30 12669110 frs-bus:SmallEntities 2023-07-01 2024-06-30 12669110 frs-bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 12669110 frs-bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 12669110 frs-bus:Director1 2023-07-01 2024-06-30 12669110 frs-bus:Director1 2023-06-30 12669110 frs-bus:Director1 2024-06-30 12669110 frs-countries:EnglandWales 2023-07-01 2024-06-30 12669110 2022-06-30 12669110 2023-06-30 12669110 2022-07-01 2023-06-30 12669110 frs-core:CurrentFinancialInstruments 2023-06-30 12669110 frs-core:Non-currentFinancialInstruments 2023-06-30 12669110 frs-core:ShareCapital 2023-06-30 12669110 frs-core:RetainedEarningsAccumulatedLosses 2023-06-30
Registered number: 12669110
Wellcare Pharma Ltd
Unaudited Financial Statements
For The Year Ended 30 June 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 12669110
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 50,773 -
50,773 -
CURRENT ASSETS
Stocks 5 115,500 55,500
Debtors 6 111,265 31,584
Cash at bank and in hand - 27,109
226,765 114,193
Creditors: Amounts Falling Due Within One Year 7 (525,176 ) (134,000 )
NET CURRENT ASSETS (LIABILITIES) (298,411 ) (19,807 )
TOTAL ASSETS LESS CURRENT LIABILITIES (247,638 ) (19,807 )
Creditors: Amounts Falling Due After More Than One Year 8 (35,677 ) -
NET LIABILITIES (283,315 ) (19,807 )
CAPITAL AND RESERVES
Called up share capital 9 1 1
Profit and Loss Account (283,316 ) (19,808 )
SHAREHOLDERS' FUNDS (283,315) (19,807)
Page 1
Page 2
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr VIMALKUMAR PATEL
Director
07/03/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Wellcare Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12669110 . The registered office is 304-B EASTCOTE LANE, HARROW, HA2 9AH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Motor Vehicles 50773
2.4. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 2)
1 2
4. Tangible Assets
Motor Vehicles
£
Cost
As at 1 July 2023 -
Additions 50,773
As at 30 June 2024 50,773
Net Book Value
As at 30 June 2024 50,773
As at 1 July 2023 -
Page 3
Page 4
5. Stocks
2024 2023
£ £
Finished goods 115,500 55,500
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors - 3,190
Other debtors 55,980 13,000
VAT 17,758 15,394
Director's loan account 37,527 -
111,265 31,584
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 503,174 120,001
Bank loans and overdrafts 20,047 -
Other taxes and social security 1,299 1,871
Accruals and deferred income 656 656
Director's loan account - 11,472
525,176 134,000
8. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Bank loans 35,677 -
9. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 1 1
10. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 July 2023 Amounts advanced Amounts repaid Amounts written off As at 30 June 2024
£ £ £ £ £
Mr VIMALKUMAR PATEL 11,472 48,999 - - 37,527
The above loan is unsecured, interest free and repayable on demand.
Page 4